Product
Ursodeoxycholic acid
Aliases
Ursodeoxycholic acid (UDCA) 500 mg
10 clinical trials
13 indications
Indication
Gestational DiabetesIndication
Liver RegenerationIndication
Ursodeoxycholic AcidIndication
Hepatic lobectomyIndication
Diabetes MellitusIndication
Type 2Indication
Cardiac surgeryIndication
COVID-19Indication
SepsisIndication
MalnutritionIndication
CHILDIndication
Clostridioides difficile infectionIndication
Rheumatoid ArthritisClinical trial
Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes MellitusStatus: Completed, Estimated PCD: 2022-02-09
Clinical trial
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy: An Open Label Randomised TrialStatus: Not yet recruiting, Estimated PCD: 2024-11-30
Clinical trial
A Clinical Study Evaluating the Use od Ursodeoxycholic Acid as Adjuvant Therapy in Type 2 Diabetes MellitusStatus: Recruiting, Estimated PCD: 2024-06-28
Clinical trial
Prophylactic Effect of Nirmatrelvir/Ritonavir and Ursodeoxycholic Acid on Reducing Complications After Cardiac Surgery During COVID-19 Pandemics: A Prospective, Randomized Controlled, Multicenter TrialStatus: Active (not recruiting), Estimated PCD: 2023-03-24
Clinical trial
Study on the Treatment of COVID-19 Infection by UDCA in Patients With Autoimmune Liver Disease and Its Clinical PrognosisStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
Pancreatic Enzymes and Bile Acids: A Non-Antibiotic Approach to Treat Intestinal Dysbiosis in Acutely Ill Severely Malnourished ChildrenStatus: Active (not recruiting), Estimated PCD: 2023-10-31
Clinical trial
Feasibility Studies to Investigate the Role of Ursodeoxycholic Acid in the Prevention of Recurrence of C. Difficile InfectionStatus: Terminated, Estimated PCD: 2023-12-31
Clinical trial
Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis in EgyptStatus: Completed, Estimated PCD: 2022-05-18
Clinical trial
Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis in EgyptStatus: Completed, Estimated PCD: 2023-11-30
Clinical trial
A Single-center, Open, Single-arm Clinical Study on the Application of Ursodeoxycholic Acid for the Prevention of SARS-CoV-2 InfectionsStatus: Completed, Estimated PCD: 2023-03-03